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ABSTRACT

This project combines is essentially a dual-faceted experiment combining two
separate fields of science in order to gain insight into the complex mechanism of cancer
in general. The first part of the experiment involves laboratory work with a concentration
on cell biology, and the second part of the experiment utilizes biotechnology in order to
analyze the significance of the cell biology results. The purpose of the experiment was to
essentially look at specific genes that are over expressed as a result of cellular conditions
that are believed to be linked to cancer but more specifically tumor metastasis. The
varying conditions were produced by adding different concentrations of the proteins
vitronectin and plasminogen activator inhibitor I (PAl-I). The interaction of PAI-I and
vitronectin alter the function of each protein in vivo, and are closely associated with the
cause of tumor metastasis. The experiment used the cancerous cell line HT 1080 and cell
culture techniques to grow the necessarily large amounts of cells for the later steps of the
experiment. Cell binding assays incorporating the different concentrations of vitronectin
and PAI-I yielded the bound cells for the RNA isolation. Once the RNA is isolated, a
microarray technology is used to analyze the different gene expression patterns that
resulted from the variables and controls.

INTRODUCTION

Cell Culture:

This experiment required a very large number of cells so that there would
eventually be enough RNA to use for the microarray. Therefore, the first and possibly
most important step to the project was to grow cells in culture flasks. The cells used,
HTI080 line, grow in a minimal media with fetal bovine serum (FBS) added to it, which
contains many essential growth factors for successful cell growth. Starting with a stock
solution of cells, these are initially added to the media with FBS. The growth of the cells
is monitored closely because the cells need to be split just before they reach confluency,
at which point the cells can start to die. This typically took approximately two days.
Once the cells were ready to be split, the media is removed from the flask and washed
with minimal media not containing FBS in order to get rid of cells that might have died
or did not adhere to the flask surface. Then the enzyme trypsin is added in a 3mL dose to
the flask. This enzyme breaks the bonds between cells and the flask surface allowing the
cells to come out into solution. After a few minutes the cells are off the plate, and 7mL
of the FBS media is added to the flask making sure not to let the trypsin begin to degrade
the cells. This 10mL is mixed and then 5mL are removed and put into another flask for
growth (splitting cells). Finally, 5mL of the FBS media is added to each of the flasks and
the process repeats until enough cells are grown. Contamination became a problem in the
cell culture process towards the end of the experiment, which was most likely caused to
some human error as a result of dealing with such a large number of cells and flasks.
However, it is possible that one ofthe bottles of media became contaminated over the
course ofthe project, which would also caused massive contamination.
Vitronectin and PAl-I:

Vitronectin, or S-protein as it is sometimes called, is a glycoprotein found in the
human blood plasma and connective tissues. Plasminogen activator inhibitor I (PAl-I) is
a serine protease inhibitor, or serpin, which is a large family of proteins. These two
proteins separately have diverse functions in the body, but for the purpose of this
experiment, the interaction between the two proteins is of importance to the project. PAIl is a unique serpin because it exists in two different forms, the latent and active forms.
The active form is structurally unstable and thus spontaneously converts back into the
more stable latent conformation. However, the interaction between vitronectin and PAI-I
stabilizes the PAl-I, which allows for a two to three fold increase in its half-life (Gibson).
Vitronectin and PAI-l are linked to many different physiological processes including the
fibrinolytic pathway, cell migration, and tumor metastasis. The purpose of this
experiment is to investigate why the interaction of these two proteins potentially causes
cancer or at least the spread of cancer. The interaction shows the ability ofvitronectin to
form multimeric complexes with P AI-l that exposes binding sites that are not available in
native unbound vitronectin (Kreis). DNA microarrays will hopefully explain the
resulting gene expression that is brought about by the interaction between PAI-l and
vitronectin.
MICROARRAY TECHNOLOGY:

The technology that would be used to analyze the effects of the vitronectin and
PAI-Ion gene expression is a DNA microarray. This technology can be used to analyze
DNA on three different levels of the central dogma. First, it is possible to analyze DNA
sequences, and this method is categorized as genomics. Next, the microarray can analyze
RNA expressed by a specific cell or system, which is categorized as functional genomics.

Finally, proteomics refers to an array that analyzes the expressed proteins. For the
purpose of this experiment, we wanted to apply the functional genomics as we look at the
RNA isolated from the HTI 080 cells after being exposed to the different vitronectin and
PAI-l conditions. This array utilizes a biochip that detects hybridization of DNA. First
off, a number of genes are selected because they are potentially linked to cancer.
Approximately 200 microns of DNA segments from these genes are spotted on a slide.
These DNA segments have a fluorescent marker attached to them as well as a quencher.
The quencher and marker are on different ends of the segment, but they are attached so
that the DNA is essentially folded on itself. This interaction between the marker and
quencher is what prevents the spots on the slide from giving off a fluorescent signal.
After the RNA isolation of the HT 1080 cells, reverse transcriptase is employed to get
DNA segments from the cells. Then, the DNA that was extracted from the cells is
applied to the slide with premarked spots on it. Finally, if any of the genes that are
spotted on the slide are being expressed in the HTI 080 cells, then there should be
hybridization of the DNA. The hybridization effect causes the quencher and the marker
to release giving off a fluorescent signal that is detected by the biochip and read on a
computer program (Grigorenko).

METHOD:

This is the protocol for the cell binding assay experiment that was performed.
The larger experiment uses the same preparation, but because of the great need for more
cells, large six well plates were used and the 100 microliters is changed to 1800
microliters. Also, once the cells are bound to the ECM, rubber scrapers would be used to

scrape the cells off of the plates. Then, using an RNA isolation kit, the RNA would be
extracted from the cells for use in the microarray described in the introduction. Those
calculations are shown in the next section. The Elisa plate was coated with ECM (BD
Bioscience) in IX PBS, in a concentration of 51lg of ECM in each one ml of PBS. The
stock of supplied ECM was 1mg/m!. In each well of plate 100111 of coating solution was
added. The plate was kept overnight at 4 °c before use.

Blocking of plate
Before starting the experiment the coated plate was washed by IX PBS three times and
then blocked by 5% BSA (made in IX PBS) and kept at 37°C for one hour.
Making solution Coating of the plate with ECM ofVN and mixture ofVN/PAI-l
All the solutions were made in 0.5% BSA (made in IX PBS). The concentration of the
stock solution ofVN and PAI-I were 28 11M and 60 11M respectively. The solutions were
kept in 37°C for one hour. Incubation time for these solutions was strictly followed.
Addition of solution of VN and VN/PAI-l to the plate
The blocking solution was removed from the plate and washed three times by 0.5% BSA.
Then different solutions of VN and VNIPAI-I were added to the plate. Then the plate
with solution was incubated for I hour at 37°C. VN was obtained by dialysis and PAI-I
came from Molecular Innovation.
Note: Solution should be added as soon as possible after its incubation is complete. So
washing should be done before the time for incubation of the solutions is finished.
Labeling of the cells

Cells (grown in MMEM using 10% FBS) were trypsinized and collected and then were
washed with serum free MMEM. The cells were then resuspended in required volume of
MMEM and counted. Before counting a solution was made by adding 20)1\ of Trypan
Blue (OIBCO) to 20 )11 of cell suspension. From this solution 20 )11 was taken in
Hemacytometer and counted. Percentage of viable cells was counted. More than 90% was
considered as fine to work with.
For labeling, Calcein (Molecular Probe) was used. SO)1g of calcein was dissolved in S0)11
of DMSO. And for each ml of cell suspension 1)11 of calcein solution was added. Cellsuspension with calcein was kept at 37°C for at least 30 minutes for labeling.
Addition of cell-suspension to the plate

After one hour of incubation with solution of VN and PAI-l the plate was washed for
three times with O.S% BSA. 100 )11 of cell suspension was added to each well of the plate
and the plate was then incubated for 1 hour in 37°C.
Counting of the signal

After incubation of the plate with cell a counting was done in Elisa Reader (Perkin
Elmer) to get total signal. Then the plates was washed three times with serum free
MMEM. A final count was done in the Elisa reader in presence of MMEM in each well.
Each time the excitation and emission spectra used were 43Snm and 535nm respectively.
Analysis of data

Data was analyzed by drawing a bar-graph between percentage of cells bound, subtracted
from the background (cells bound to ECM alone) with respect to different concentrations
of PAI-I in Kaleidagraph.
The formula of calculating percentage of cell bound is .....

={(Observed signal-average signal of background)/Average of total signal measured before wash}*100

Results:
These are results of the cell binding assay perfonned by Sumit Goswami in Dr.
Peterson's lab.
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Since the majority of the experiment was not perfonned due to time constraints, there is
not much to display as results.

CONCLUSION:
It is likely that had the cells not become contaminated, there would have been

enough cells to do some RNA isolation work. However, there were many problems
throughout the project's duration that hindered its productivity. In theory, ifvitronectin
and PAl -1 have a serious physiological effect that is linked with tumor metastasis, then

hopefully the DNA microan'ay would yield specific genes that are being overexpressed as
a result of the interaction of these two proteins. If results like this were reproducible, this
would give someone a reason to investigate the genes that are being expressed, and
hopefully they would gain insight on cancer. The clinical potential that an experiment
like this has is incredible, and hopefully a successful project will lead to a more effective
treatment for cancer.
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